|
Q1
|
Beginning of step 1
|
Public
|
Public representatives' sociodemographic data (age, gender, ethnic group, language, education, socioeconomic status, health status, health services use, prior attitude toward public involvement)
|
|
Q2
|
End of step 1
|
Public
|
Quality-indicators prioritisation (public baseline priorities)
|
|
Q3
|
End of step 1
|
Public
|
Participants' evaluation of the step 1 meeting
|
|
Q4
|
Step 2 and step 3 meetings
|
Clinicians and managers
|
Clinicians and managers' sociodemographic data (age, gender, ethnic group, language, education, socioeconomic status, professional role, prior attitude toward public involvement)
|
|
Q5
|
Beginning of step 2
|
Clinicians and managers
|
Quality-indicator prioritisation (clinicians and managers' baseline priorities)
|
|
Q6
|
End of step 2
|
Clinicians, managers, and public representatives
|
Quality-indicator prioritisation (postdeliberation priorities)
|
|
Q7
|
End of step 2
|
Clinicians, managers, and public representatives
|
Participants' evaluation of the step 2 meeting
|
|
Q8
|
End of step 3
|
Clinicians, managers, and public representatives
|
Quality-indicator prioritisation, attitude and intention to use the selected indicators for quality improvement (decision makers' choice and intention to use)
|
|
Q9
|
End of step 3
|
Clinicians and managers (control sites only)
|
Quality-indicator prioritisation (postconsultation priorities); this questionnaire is completed after we collect data on decision makers' choice and intention to use, and after we present results of public consultation to control sites
|
|
Q10
|
End of step 3
|
Clinicians, managers, and public representatives
|
Participants' evaluation of the step 3 meeting
|
